Figure 5: The US Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-Name Drugs
Figure 11: The Median Medicare Part D Plan: Total Cost by Drug From, “Why Drug Pricing Reform is Complicated: A Primer and Policy Guide to Pharmaceutical Prices in the US,” by Craig Garthwaite and Amanda Starc.
Figure 8: Type of Cost Sharing for Prescription Drug Benefits, Employer-Sponsored Plans Without High Deductibles, by Benefit Tier, 2022
Figure 6: Pharmaceutical Manufacturers’ Off-Invoice Discounts, Rebates, and Price Concessions, 2008-2022